CM
MRNA icon

Capula Management’s Moderna MRNA Stock Holding History

Capula Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,700
Closed -$589K – 478
2023
Q3 		$589K Sell
5,700
-13,300
-70% -$1.48M 0.01% 306
2023
Q2 		$2.31M Sell
19,000
-36,000
-65% -$4.8M 0.06% 132
2023
Q1 		$8.45M Buy
+55,000
New +$9.07M 0.1% 173

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's MRNA Position: Q1 2026 in Review

Capula Management opened a new position in Moderna (MRNA) in Q1 2026: 14,500 shares worth $737K. The stake represents 0.01% of the portfolio and ranks #423 among its holdings. This is a return to the name: Capula Management previously reported a position in MRNA as recently as Q2 2025.

Capula Management first reported a position in MRNA in Q2 2021 and has held it in 10 quarters since. The position peaked at $962K in Q3 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Capula Management held 14,500 shares of Moderna worth $737K as of Q1 2026.
  • Moderna was a new Capula Management position in Q1 2026.
  • Moderna made up 0.01% of Capula Management's portfolio in Q1 2026, its #423 holding.
  • Capula Management first reported a position in Moderna in Q2 2021 and has held it in 10 quarters since.
  • Capula Management's Moderna position peaked at $962K in Q3 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.